A critical discovery in cancer investigation is emerging with the use of nanobodies to re-engage mutated p53. This vital tumor protector protein is frequently inactivated in several forms of malignancies, resulting https://bookmarkfame.com/story21788892/mini-antibodies-restore-tumor-suppressor-p53-a-potential-approach-for-cancer-management